powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1114029329
Aditi Bhaduri
M.D.
Endocrinology
Roseville,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 051305
Hospital
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
188
Unique beneficiaries
—
Total services
436
Distinct HCPCS
7
Medicare payment
$27K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 633 Endocrinology providers in CA — below median (cohort median 1,164).
PRESCRIBING · PART D · 2024
Total Rx claims
205
Beneficiaries
—
Total drug cost
$105K
Distinct drugs
8
Brand share
93.2%
Top prescribed drugs
Tirzepatide
38 claims
Insulin Glargine,hum.Rec.Anlog
23 claims
Dulaglutide
20 claims
Dapagliflozin Propanediol
18 claims
Levothyroxine Sodium
18 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
